Beranda › Leukemia Limfoblastik Akut › Tennessee
Uji klinis Leukemia Limfoblastik Akut di Tennessee
22 studi untuk Leukemia Limfoblastik Akut mencari peserta di lokasi di Tennessee.
Kota di Tennessee
Teks studi resmi (Bahasa Inggris)
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
- TriStar Bone Marrow Transplant / Sarah Cannon Transplant & Cellular Therapy, Nashville
Menerima pesertaFase 2
6 Months · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06514794Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors
- St. Jude Children's Research Hospital, Memphis
Menerima pesertaSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06819475Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia
- St. Jude Children's Research Hospital, Memphis
Menerima pesertaFase 1
Hingga usia 21 · Semua jenis kelamin · Diperbarui 31 Agu 2026 · NCT04881240CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma
- St. Jude Children's Research Hospital, Memphis
Menerima pesertaFase 1
Hingga usia 21 · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT07257419The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- East Tennessee Childrens Hospital, Knoxville
- Saint Jude Children's Research Hospital, Memphis
- The Children's Hospital at TriStar Centennial, Nashville
- dan 1 lainnya
Menerima pesertaFase 1/2
Hingga usia 22 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT04726241A Study of CTD402 in T-ALL/LBL Patients
- Sarah Cannon Research Insitute, Nashville
Menerima pesertaFase 1/2
Usia 1 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT07070219Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia
- St. Jude Children's Research Hospital, Memphis
Menerima peserta
Usia 20 hingga 50 · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT07191119Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
- Vanderbilt University Medical Center, Nashville
Menerima pesertaStudi observasional
1 Day – 17 Years · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT06274788Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
- St. Jude Children's Research Hospital, Memphis
Menerima pesertaFase 2
Usia 1 hingga 18 · Semua jenis kelamin · Diperbarui 16 Jul 2026 · NCT06533748Assessment of Remote Approaches for Identification of Autonomic Dysfunction Among Survivors of Leukemia and Lymphoma
- St. Jude Children's Research Hospital, Memphis
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Jul 2026 · NCT06747910Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
- St. Jude Children's Research Hospital, Memphis
Menerima pesertaFase 4
Usia 1 hingga 18 · Semua jenis kelamin · Diperbarui 14 Jul 2026 · NCT06289673Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
- Research Site, Franklin
Menerima pesertaFase 1/2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 13 Jul 2026 · NCT07109219A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- St. Jude Childrens Research Hospital, Memphis
- Vanderbilt University, Nashville
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT01351545Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity
- St. Jude Children's Research Hospital, Memphis
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Jun 2026 · NCT07228741Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase
- St. Jude Children's Research Hospital, Memphis
Menerima pesertaFase 1/2
Hingga usia 21 · Semua jenis kelamin · Diperbarui 3 Jun 2026 · NCT04195347CD19-CD22-Bispecific Chimeric Antigen Receptor (CAR) T Cell Therapy for Pediatric Patients With Acute Lymphoblastic Leukemia
- St. Jude Children's Research Hospital, Memphis
Menerima pesertaFase 1
Hingga usia 21 · Semua jenis kelamin · Diperbarui 19 Mei 2026 · NCT06777979CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive Leukemia
- St. Jude Children's Research Hospital, Memphis
Menerima pesertaFase 2
Hingga usia 21 · Semua jenis kelamin · Diperbarui 25 Mar 2026 · NCT06847269A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- TriStar Centennial Medical Center, Nashville
Menerima pesertaFase 1/2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 24 Mar 2026 · NCT04988555CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies
- St. Jude Children's Research Hospital, Memphis
Menerima pesertaFase 1
Hingga usia 21 · Semua jenis kelamin · Diperbarui 23 Jan 2026 · NCT06326463Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
- St. Jude Children's Research Hospital, Memphis
Menerima pesertaFase 2
Usia 10 hingga 30 · Semua jenis kelamin · Diperbarui 4 Des 2025 · NCT05194397HPC Offered for PRESERVE Expansion
- Tristar Centennial Medical Center, Nashville
Menerima pesertaStudi observasional
Usia 12 hingga 80 · Semua jenis kelamin · Diperbarui 28 Agu 2025 · NCT07145411Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- St. Jude Children's Research Hospital, Memphis
Menerima pesertaFase 1
Usia 1 hingga 21 · Semua jenis kelamin · Diperbarui 6 Des 2024 · NCT05476770Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.